AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Metafin-G 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Medford Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metafin-G 1 Tablet PR

GlucoTwin-D, a single-dose tablet, belongs to the anti-diabetic medication class. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer GlucoTwin-D with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication even if feeling well or experiencing controlled blood sugar; abrupt cessation without consulting your doctor can elevate blood glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as directed by your physician. Lifestyle adjustments are crucial for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Learn to identify and manage these symptoms. Maintain regular mealtimes and always carry a fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your doctor prior to use. Pregnant or breastfeeding individuals should seek medical advice before starting this medication. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Metafin-G 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Metafin-G 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Metafin-G 1 Tablet PR with a meal.

Common Side effects of Metafin-G 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metafin-G 1 Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take one Metafin-G PR tablet with food.

How Metafin-G 1 Tablet PR works:

Metafin-G 1 Tablet PR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Metafin-G 1 Tablet PR ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metafin-G 1 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Administration of Metafin-G 1 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metafin-G 1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Renal function should be regularly monitored during treatment; physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Metafin-G 1 Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate hepatic dysfunction, initiating treatment with a low dose of Metafin-G 1 Tablet PR is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Metafin-G 1 Tablet PR :

Should you forget to take a Metafin-G 1 Tablet PR, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metafin-G 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metafin-G 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metafin-G 1 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metafin-G 1 Tablet PR and seek immediate medical attention.
Metafin-G 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It improves blood sugar control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Metafin-G 1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Metafin-G 1 Tablet PR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may cause anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Yes, Metafin-G 1 Tablet PR can lower blood sugar (cause hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metafin-G 1 Tablet PR with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Metafin-G 1 Tablet PR
54
MRP 66
18% off